Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study

Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study

Background: Epirubicin, cisplatin, and 5-FU (ECF) is one of the most commonly used first-line chemotherapy regimens in metastatic gastric cancer. However, due to protracted infusion schedule, need for special infusion pumps, and catheter-related complications, the practical utility and acceptability...

Full description

Bibliographic Details
Main Authors: K Govind Babu, Tamojit Chaudhuri, K C Lakshmaiah, Lokanatha Dasappa, Linu Abraham Jacob, M C Suresh Babu, A H Rudresha, K N Lokesh, L K Rajeev
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-01-01
Series:South Asian Journal of Cancer
Subjects:
Gastric cancer
modified epirubicin
cisplatin and 5-FU regimen
systemic chemotherapy
Online Access:http://journal.sajc.org/article.asp?issn=2278-330X;year=2019;volume=8;issue=2;spage=85;epage=87;aulast=Babu

Internet

http://journal.sajc.org/article.asp?issn=2278-330X;year=2019;volume=8;issue=2;spage=85;epage=87;aulast=Babu

Similar Items